Inter Parfums (IPAR) Competitors

Inter Parfums (NASDAQ:IPAR) and Prestige Consumer Healthcare (NYSE:PBH) are both mid-cap consumer discretionary companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, media sentiment, community ranking, earnings and profitability.

Do insiders and institutionals believe in IPAR or PBH?

55.6% of Inter Parfums shares are owned by institutional investors. Comparatively, 99.9% of Prestige Consumer Healthcare shares are owned by institutional investors. 43.9% of Inter Parfums shares are owned by insiders. Comparatively, 1.6% of Prestige Consumer Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Does the media favor IPAR or PBH?

In the previous week, Inter Parfums and Inter Parfums both had 13 articles in the media. Prestige Consumer Healthcare's average media sentiment score of 1.00 beat Inter Parfums' score of 0.68 indicating that Prestige Consumer Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inter Parfums	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Prestige Consumer Healthcare	7 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community favor IPAR or PBH?

Prestige Consumer Healthcare received 27 more outperform votes than Inter Parfums when rated by MarketBeat users. Likewise, 70.35% of users gave Prestige Consumer Healthcare an outperform vote while only 65.14% of users gave Inter Parfums an outperform vote.

Company	Underperform	Outperform
Inter Parfums	Outperform Votes 469 65.14%	Underperform Votes 251 34.86%
Prestige Consumer Healthcare	Outperform Votes 496 70.35%	Underperform Votes 209 29.65%

Is IPAR or PBH more profitable?

Prestige Consumer Healthcare has a net margin of 19.13% compared to Inter Parfums' net margin of 10.60%. Inter Parfums' return on equity of 16.34% beat Prestige Consumer Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inter Parfums	10.60%	16.34%	10.82%
Prestige Consumer Healthcare	19.13%	12.36%	6.39%

Which has preferable valuation and earnings, IPAR or PBH?

Prestige Consumer Healthcare has lower revenue, but higher earnings than Inter Parfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Inter Parfums, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inter Parfums	$1.45B	2.62	$152.65M	$5.09	23.29
Prestige Consumer Healthcare	$1.12B	3.77	$209.34M	$4.27	19.92

Which has more volatility & risk, IPAR or PBH?

Inter Parfums has a beta of 1.18, indicating that its share price is 18% more volatile than the S&P 500. Comparatively, Prestige Consumer Healthcare has a beta of 0.46, indicating that its share price is 54% less volatile than the S&P 500.

Is IPAR or PBH a better dividend stock?

Inter Parfums pays an annual dividend of $3.20 per share and has a dividend yield of 2.7%. Prestige Consumer Healthcare pays an annual dividend of $1.90 per share and has a dividend yield of 2.2%. Inter Parfums pays out 62.9% of its earnings in the form of a dividend. Prestige Consumer Healthcare pays out 44.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Do analysts rate IPAR or PBH?

Inter Parfums currently has a consensus target price of $162.80, indicating a potential upside of 37.31%. Prestige Consumer Healthcare has a consensus target price of $93.33, indicating a potential upside of 9.75%. Given Inter Parfums' stronger consensus rating and higher probable upside, equities research analysts clearly believe Inter Parfums is more favorable than Prestige Consumer Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inter Parfums	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Prestige Consumer Healthcare	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Inter Parfums beats Prestige Consumer Healthcare on 11 of the 19 factors compared between the two stocks.